Clinical Trial Update: A Study to Explore the Utility of Fractional Exhaled Nitric Oxide (FeNO) Compared With Methacholine Challenge (MCC) Testing in the Assessment of Patients With Suspected But Undiagnosed Asthma

View source ↗

Summary

A completed study comparing fractional exhaled nitric oxide testing with methacholine challenge for evaluating patients with suspected but undiagnosed asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Aerocrine AB | Conditions: Asthma | Status: COMPLETED | Results posted: 2014-04-09